vTv Therapeutics | 4:持股变动声明-董事 BAKER BROS. ADVISORS LP
vTv Therapeutics | 4:持股变动声明-董事 SPIEGELMAN DANIEL K
vTv Therapeutics | 4:持股变动声明-董事 Al-Marzooqi Fahed
vTv Therapeutics | 4:持股变动声明-董事 Phillips Anne M.
vTv Therapeutics | 4:持股变动声明-董事 AKKARAJU SRINIVAS
vTv Therapeutics | 4:持股变动声明-高管 SEKHRI PAUL J
vTv Therapeutics | 4:持股变动声明-董事 Al-Marzooqi Fahed
vTv Therapeutics | 4:持股变动声明-董事 Phillips Anne M.
vTv Therapeutics | 4:持股变动声明-高管 Tuch Steven L.
vTv Therapeutics | 3:首次持股声明-董事 SPIEGELMAN DANIEL K
vTv Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-The ROP Revocable Trust dated 1/9/2018(50.3%),MacAndrews & Forbes Incorporated(47.8%)等
vTv Therapeutics | 3:首次持股声明-董事 Phillips Anne M.
vTv Therapeutics | 4:持股变动声明-董事 BAKER BROS. ADVISORS LP
vTv Therapeutics | 3:首次持股声明-董事 BAKER BROS. ADVISORS LP
vTv Therapeutics | 3:首次持股声明-董事 Cheong Raymond
vTv Therapeutics | D:发行公告
vTv Therapeutics | SC 13D:超过5%持股股东披露文件-Samsara BioCapital, L.P.(10.4%),Samsara BioCapital GP, LLC(10.4%)等
vTv Therapeutics | SC 13D:超过5%持股股东披露文件-Baker Bros. Advisors LP(4.99%),Baker Bros. Advisors (GP) LLC(4.99%)等
vTv Therapeutics | 3:首次持股声明-股东 Samsara BioCapital GP, LLC
vTv Therapeutics | 4:持股变动声明-董事 AKKARAJU SRINIVAS
暂无数据
暂无数据